- Home
- NMTC vs PULM Comparison
NMTC vs PULM Comparison
Compare NMTC & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMTC
- PULM
- Stock Information
- Founded
- NMTC 2009
- PULM 2003
- Country
- NMTC United States
- PULM United States
- Employees
- NMTC N/A
- PULM N/A
- Industry
- NMTC Medical/Dental Instruments
- PULM Biotechnology: Pharmaceutical Preparations
- Sector
- NMTC Health Care
- PULM Health Care
- Exchange
- NMTC Nasdaq
- PULM Nasdaq
- Market Cap
- NMTC 30.9M
- PULM 28.3M
- IPO Year
- NMTC N/A
- PULM N/A
- Fundamental
- Price
- NMTC $0.58
- PULM $8.89
- Analyst Decision
- NMTC Strong Buy
- PULM
- Analyst Count
- NMTC 1
- PULM 0
- Target Price
- NMTC $1.45
- PULM N/A
- AVG Volume (30 Days)
- NMTC 254.0K
- PULM 24.5K
- Earning Date
- NMTC 05-13-2025
- PULM 05-15-2025
- Dividend Yield
- NMTC N/A
- PULM N/A
- EPS Growth
- NMTC N/A
- PULM N/A
- EPS
- NMTC N/A
- PULM N/A
- Revenue
- NMTC $5,758,777.00
- PULM $1,921,000.00
- Revenue This Year
- NMTC $141.04
- PULM N/A
- Revenue Next Year
- NMTC $38.86
- PULM $134.88
- P/E Ratio
- NMTC N/A
- PULM N/A
- Revenue Growth
- NMTC 54.53
- PULM N/A
- 52 Week Low
- NMTC $0.40
- PULM $1.78
- 52 Week High
- NMTC $1.39
- PULM $10.40
- Technical
- Relative Strength Index (RSI)
- NMTC 42.35
- PULM 65.38
- Support Level
- NMTC $0.55
- PULM $8.49
- Resistance Level
- NMTC $0.62
- PULM $9.16
- Average True Range (ATR)
- NMTC 0.04
- PULM 0.66
- MACD
- NMTC -0.00
- PULM 0.18
- Stochastic Oscillator
- NMTC 25.56
- PULM 85.32
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).